Michel De Vos
Overview
Explore the profile of Michel De Vos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1574
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coticchio G, Cimadomo D, De Vos M, Ebner T, Esbert M, Escriba M, et al.
Fertil Steril
. 2025 Mar;
PMID: 40058555
In vitro maturation (IVM) of immature oocytes has been explored for research and clinical purposes since the dawn of assisted reproduction technologies. Oocyte maturation is a highly specific process, based...
2.
Cava-Cami B, Galvao A, Van Ranst H, Stocker W, Harrison C, Smitz J, et al.
Mol Hum Reprod
. 2025 Jan;
31(1).
PMID: 39862403
Biphasic IVM can be offered as a patient-friendly alternative to conventional ovarian stimulation in IVF patients predicted to be hyper-responsive to ovarian stimulation. However, cumulative live birth rates after IVM...
3.
Li Piani L, Schoonjans B, De Vos M, Tournaye H, Blockeel C
J Assist Reprod Genet
. 2025 Jan;
42(2):441-449.
PMID: 39798009
Purpose: This survey aimed to assess the public's knowledge and opinions on oocyte donation (OD) among a large, unselected cohort of young Belgian women, and to explore aspects that could...
4.
Nauwynck E, De Vos M, Gheldof A, Dequeker B, Van Der Kelen A, Hes F, et al.
Endocrinol Diabetes Metab Case Rep
. 2024 Oct;
2024(4).
PMID: 39447595
Summary: Delayed puberty in girls is often related to late maturation but is occasionally the first sign of premature ovarian insufficiency (POI). POI is a condition that affects ovarian function...
5.
Federica D, De Rijdt S, Racca A, Drakopoulos P, Mackens S, Strypstein L, et al.
PLoS One
. 2024 Oct;
19(10):e0308666.
PMID: 39374231
The study investigates whether a 3-day pretreatment course with a GnRH antagonist in the early follicular phase has an impact on the number of retrieved COCs in a GnRH antagonist...
6.
Morice P, Scambia G, Abu-Rustum N, Acien M, Arena A, Brucker S, et al.
Lancet Oncol
. 2024 Aug;
25(11):e602-e610.
PMID: 39216500
The European Society of Gynaecological Oncology, the European Society of Human Reproduction and Embryology, and the European Society for Gynaecological Endoscopy jointly developed clinically relevant and evidence-based guidelines focusing on...
7.
Li Piani L, Tshilembi A, De Vos M, Buyse E, Ruttens S, Somigliana E, et al.
J Assist Reprod Genet
. 2024 Jul;
41(9):2337-2347.
PMID: 39042340
Purpose: In this survey, we aimed to provide the description of previous oocyte donors' profile in a Belgian tertiary fertility hospital clinic. The research question is as follows: could certain...
8.
De Vos M, Segers I, Yuan Y, Gilchrist R, Kramme C
Fertil Steril
. 2024 Jun;
122(4):753-755.
PMID: 38838807
Objective: To demonstrate clinical techniques for in vitro maturation (IVM) treatment, including stimulation recommendations, small follicle pick-up procedures, and compact cumulus-oocyte complex (COC) search practice. Design: This video utilizes live-action...
9.
Segers I, Mateizel I, Wouters K, Van Moer E, Anckaert E, De Munck N, et al.
J Vis Exp
. 2024 Jun;
(207).
PMID: 38829044
Mature oocyte vitrification is the standard of care to preserve fertility in women at risk of infertility. However, ovarian tissue cryopreservation (OTC) is still the only option to preserve fertility...
10.
De Rijdt S, Illingworth K, De Munck N, Tournaye H, Mackens S, De Vos M, et al.
Reprod Biomed Online
. 2024 May;
49(2):103889.
PMID: 38763121
Research Question: Is late follicular phase stimulation as efficient as early follicular phase stimulation in a gonadotrophin-releasing hormone (GnRH) antagonist protocol in oocyte donors in terms of the number of...